Rituximab (anti-CD20 monoclonal antibody) as single first-line therapy for patients with follicular lymphoma with a low tumor burden: clinical and molecular evaluation
(Q60685688)
scientific article published on 01 January 2001
scientific article published on 01 January 2001
Language:
Current Data About
Rituximab (anti-CD20 monoclonal antibody) as single first-line therapy for patients with follicular lymphoma with a low tumor burden: clinical and molecular evaluation
other details
| description | scientific article published on 01 January 2001 |
External Links
| (P356) |
10.1182/BLOOD.V97.1.101
|
| (P698) |
11133748
|